← All presentations

Technology 4 slides

Why does the BI team always question the accuracy of stockout and distribution data?

BI's demand for data auditing in the pharmaceutical channel makes sense, but trust comes from clarity on limits and sources, not from illusions of perfection.

Why does the BI team always question the accuracy of stockout and distribution data?

BI's demand for data auditing in the pharmaceutical channel makes sense, but trust comes from clarity on limits and sources, not from illusions of perfection.

Part 1

When a laboratory decides to structure the reading of the pharmaceutical channel, the BI team's first move is predictable and correct: requesting raw access, cross-referencing databases, and questioning the accuracy of each distribution and stockout metric before releasing any dashboard to operations. The demand for technical validation is legitimate.

Part 2

The transition between technical distrust and the effective use of information requires rigorously separating concepts that are usually treated as equivalent. It is necessary to distinguish data observed directly at the point of sale from that which was calculated, estimated, or predicted by statistical inference.

Part 3

Trust in a commercial intelligence layer does not arise from a magic number that requires no checking, but from transparency regarding the origin, update date, and degree of confidence of each indicator. When the technical team can audit the origin and processing of the data, the debate changes shape.

Read the full article →

Turn data into decisions

Dinn shows where pharmacies lack the product, what changed and where to act first, with source and confidence.

Other presentations